American journal of clinical oncology
-
Am. J. Clin. Oncol. · Apr 2007
A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy alone.
The objective of this study was to describe a simple model that predicts freedom from biochemical recurrence (FFBR) in men with prostate cancer after treatment with low-dose rate prostate brachytherapy (LDRPB) alone. ⋯ We have developed a simple, robust model based on implant quality and disease factors that predicts FFBR in men with prostate cancer treated with LDRPB alone.